Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Future Oncology
Volume 13, Issue 11, Pages 1021-1034
Publisher
Future Medicine Ltd
Online
2017-01-16
DOI
10.2217/fon-2016-0428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
- (2015) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy
- (2015) N. Yamazaki et al. EJSO
- A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
- (2015) L. Kostakoglu et al. JOURNAL OF NUCLEAR MEDICINE
- Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
- (2014) A. Sheri et al. ANNALS OF ONCOLOGY
- Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
- (2014) E. Montagna et al. ANNALS OF ONCOLOGY
- Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer
- (2014) Yumi Hashimoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR
- (2014) Nobuaki Matsubara et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Factors of Survival in Pathologic Incomplete Response Patients with Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
- (2014) Ou Huang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
- (2013) C. Denkert et al. ANNALS OF ONCOLOGY
- Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
- (2013) S. Ohno et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value
- (2013) Alfonso Sánchez-Muñoz et al. Clinical Breast Cancer
- Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
- (2013) G. von Minckwitz et al. CLINICAL CANCER RESEARCH
- The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer
- (2013) S. Chen et al. EJSO
- A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: Extension and analysis of a previously reported cohort of patients
- (2013) L. Miglietta et al. EJSO
- Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
- (2013) Liang Huang et al. World Journal of Surgical Oncology
- FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer
- (2013) Mai Kawase et al. Breast Cancer
- Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
- (2013) Tatsuya Yoshioka et al. Breast Cancer
- Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients
- (2012) David L. Wachter et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer
- (2012) Nobuaki Matsubara et al. BREAST CANCER RESEARCH AND TREATMENT
- Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients
- (2012) Guo-Chun Zhang et al. MEDICAL ONCOLOGY
- Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy
- (2011) B. Y. S. Chuah et al. ANNALS OF ONCOLOGY
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer
- (2011) Sheng Chen et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Value of Estrogen Receptor and Ki-67 Index after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Expressing High Levels of Proliferation at Diagnosis
- (2011) L. Miglietta et al. ONCOLOGY
- Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
- (2010) Emilia Montagna et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
- (2010) Hiroko Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group
- (2010) Helen Gogas et al. Clinical Breast Cancer
- Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
- (2010) T. Tanei et al. EJSO
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
- (2010) Abigail S. Caudle et al. JOURNAL OF CLINICAL ONCOLOGY
- A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
- (2009) V. Guarneri et al. ANNALS OF ONCOLOGY
- A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer
- (2009) M. Colleoni et al. ANNALS OF ONCOLOGY
- Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months
- (2009) Ou Huang et al. BMC CANCER
- Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer
- (2009) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Should Histologic Type be Taken into Account when Considering Neoadjuvant Chemotherapy in Breast Carcinoma?
- (2009) Peggy S. Sullivan et al. Breast Journal
- Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
- (2009) Reiki Nishimura et al. Breast Cancer
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer
- (2008) E Montagna et al. BRITISH JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started